GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Numinus Wellness Inc (TSX:NUMI) » Definitions » YoY EBITDA Growth

Numinus Wellness (TSX:NUMI) YoY EBITDA Growth : 20.00% (As of Feb. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Numinus Wellness YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Numinus Wellness's YoY EBITDA Growth for the quarter that ended in Feb. 2024 was 20.00%.

Numinus Wellness's EBITDA per Share for the three months ended in Feb. 2024 was C$-0.02.


Numinus Wellness YoY EBITDA Growth Historical Data

The historical data trend for Numinus Wellness's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Numinus Wellness YoY EBITDA Growth Chart

Numinus Wellness Annual Data
Trend Aug19 Aug20 Aug21 Aug22 Aug23
YoY EBITDA Growth
- -49.46 21.58 -81.65 48.99

Numinus Wellness Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.43 22.58 67.35 33.33 20.00

Numinus Wellness YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Numinus Wellness's YoY EBITDA Growth for the fiscal year that ended in Aug. 2023 is calculated as:

YoY EBITDA Growth (A: Aug. 2023 )
=(EBITDA per Share (A: Aug. 2023 )-EBITDA per Share (A: Aug. 2022 ))/ | EBITDA per Share (A: Aug. 2022 ) |
=(-0.101--0.198)/ | -0.198 |
=48.99 %

Numinus Wellness's YoY EBITDA Growth for the quarter that ended in Feb. 2024 is calculated as:

YoY EBITDA Growth (Q: Feb. 2024 )
=(EBITDA per Share (Q: Feb. 2024 )-EBITDA per Share (Q: Feb. 2023 )) / | EBITDA per Share (Q: Feb. 2023 )) |
=(-0.02--0.025)/ | -0.025 |
=20.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Numinus Wellness YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Numinus Wellness's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Numinus Wellness (TSX:NUMI) Business Description

Traded in Other Exchanges
Address
801 - 33 Water Street, Vancouver, BC, CAN, V6B 1R4
Numinus Wellness Inc develops proprietary, psychedelic-centered, therapeutic products and services through its laboratory and research & development processes. The company's clinic network consists of Numinus Health, Mindspace Services, and the Neurology Center of Toronto. Its services include Ketamine-assisted psychotherapy for depression, neurological care, psychotherapy, and counseling by registered psychologists among others. The company's operating segments are; Clinical research operations, Canadian clinic network, US clinic network and Corporate. The majority of the revenue for the company is generated from US clinic network segment. Geographically, the company has its presence in United States and Canada.

Numinus Wellness (TSX:NUMI) Headlines

No Headlines